Jump to:
loading...| Preferred Name |
gefitinib |
|
| Synonyms |
N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine ZD1839 |
|
| Definitions |
This is any condition in which the main influencing factor is gefitinib, an EGFR (epidermal growth factor receptor) tyrosine kinase inhibitor used for the treatment of non-small cell lung cancer. |
|
| ID |
http://purl.obolibrary.org/obo/XCO_0001239 |
|
| created_by |
slaulederkind |
|
| creation_date |
2024-01-15T13:18:12Z |
|
| database_cross_reference |
CID:123631 MESH:D000077156 |
|
| definition |
This is any condition in which the main influencing factor is gefitinib, an EGFR (epidermal growth factor receptor) tyrosine kinase inhibitor used for the treatment of non-small cell lung cancer. |
|
| has_exact_synonym |
N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine ZD1839 |
|
| has_obo_namespace |
experimental_condition_ontology |
|
| id |
XCO:0001239 |
|
| label |
gefitinib |
|
| notation |
XCO:0001239 |
|
| prefLabel |
gefitinib |
|
| treeView | ||
| subClassOf |
Create mapping